HCA Healthcare, Inc. $HCA Stake Decreased by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.3% during the third quarter, Holdings Channel reports. The institutional investor owned 325,913 shares of the company’s stock after selling 14,683 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in HCA Healthcare were worth $139,080,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in HCA. BlackRock Inc. acquired a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $5,069,974,000. Wellington Management Group LLP increased its position in shares of HCA Healthcare by 20.5% during the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after purchasing an additional 799,761 shares during the period. Darsana Capital Partners LP raised its stake in shares of HCA Healthcare by 46.7% in the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after purchasing an additional 350,000 shares in the last quarter. Legal & General Group Plc acquired a new position in shares of HCA Healthcare in the second quarter valued at $410,992,000. Finally, Jupiter Topco LLC bought a new position in HCA Healthcare in the second quarter worth $371,138,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Robert W. Baird boosted their price target on shares of HCA Healthcare from $393.00 to $409.00 and gave the company a “neutral” rating in a report on Wednesday, October 28th. Barclays raised their price objective on shares of HCA Healthcare from $387.00 to $401.00 and gave the stock an “equal weight” rating in a report on Thursday. TD Cowen upped their target price on shares of HCA Healthcare from $460.00 to $486.00 and gave the company a “buy” rating in a research note on Wednesday, October 28th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research report on Friday, October 2nd. Finally, JPMorgan Chase & Co. cut their price target on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a research note on Thursday, August 20th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $479.48.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $467.89 on Tuesday. The company’s fifty day moving average is $438.21 and its 200-day moving average is $444.84. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52. The company has a market capitalization of $101.30 billion, a PE ratio of 15.50, a P/E/G ratio of 1.53 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.65 by $0.57. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The business had revenue of $19.85 billion during the quarter, compared to analysts’ expectations of $19.33 billion. During the same quarter last year, the company posted $6.96 EPS. The firm’s revenue for the quarter was up 3.6% on a year-over-year basis. On average, analysts forecast that HCA Healthcare, Inc. will post 30.15 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio is currently 10.34%.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Wells Fargo raised its price target for HCA from $381 to $468 while maintaining an “equal weight” rating. The higher target reflects improved valuation support, although the rating signals limited expected upside at current levels. Wells Fargo HCA price-target update
• Positive Sentiment: HCA’s price target was also raised to $521 in a separate analyst update, while KeyCorp reportedly strengthened its earnings-per-share estimates. These revisions may support investor confidence in the company’s earnings outlook. HCA price target raised to $521 KeyCorp HCA EPS estimate update
• Neutral Sentiment: An HCA subsidiary is planning a senior-notes offering. The financing could provide capital for operations or investment, but it would also increase debt obligations; terms such as pricing and size will determine the ultimate impact. HCA subsidiary senior-notes offering HCA senior notes offering
• Neutral Sentiment: HCA released renderings for a planned $300 million hospital in Cape Coral, Florida, with tax support. The project points to long-term expansion but may require substantial capital before contributing meaningfully to earnings. HCA Cape Coral hospital project
• Negative Sentiment: A reported HCA data breach affected approximately 55,000 people, creating potential costs related to remediation, regulatory scrutiny and reputational damage. HCA data breach
• Negative Sentiment: Reports warn of payer pressure ahead of HCA’s 2027 outlook. Concerns over reimbursement rates and negotiations could weigh on margins and temper the benefit of stronger earnings estimates. HCA payer pressure outlook

HCA Healthcare Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.